Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Prognostic values of serum tenascin-C in patients with ischaemic heart disease and heart failure.

Yao HC, Han QF, Zhao AP, Yao DK, Wang LX.

Heart Lung Circ. 2013 Mar;22(3):184-7. doi: 10.1016/j.hlc.2012.10.005. Epub 2012 Nov 21.

PMID:
23177647
2.

Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.

Fujimoto N, Onishi K, Sato A, Terasaki F, Tsukada B, Nozato T, Yamada T, Imanaka-Yoshida K, Yoshida T, Ito M, Hiroe M.

J Card Fail. 2009 Dec;15(10):898-905. doi: 10.1016/j.cardfail.2009.06.443. Epub 2009 Aug 26.

PMID:
19944367
3.

Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.

Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.

J Am Coll Cardiol. 2008 Jul 22;52(4):266-72. doi: 10.1016/j.jacc.2008.03.050.

4.

Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy.

Terasaki F, Okamoto H, Onishi K, Sato A, Shimomura H, Tsukada B, Imanaka-Yoshida K, Hiroe M, Yoshida T, Kitaura Y, Kitabatake A; Study Group for Intractable Diseases by a Grant from the Ministry of Health, Labor and Welfare of Japan.

Circ J. 2007 Mar;71(3):327-30.

5.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

6.

Natriuretic peptide system is not exhausted in severe heart failure.

Lourenço P, Azevedo A, Araújo JP, Bettencourt P.

J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):39-43.

PMID:
19708225
7.

Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.

Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA.

Am J Cardiol. 2009 Jun 15;103(12):1753-9. doi: 10.1016/j.amjcard.2009.02.029.

PMID:
19539088
8.

Prognostic value of serum tenascin-C levels on long-term outcome after acute myocardial infarction.

Sato A, Hiroe M, Akiyama D, Hikita H, Nozato T, Hoshi T, Kimura T, Wang Z, Sakai S, Imanaka-Yoshida K, Yoshida T, Aonuma K.

J Card Fail. 2012 Jun;18(6):480-6. doi: 10.1016/j.cardfail.2012.02.009. Epub 2012 Mar 28.

PMID:
22633306
9.

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology.

Broch K, Ueland T, Nymo SH, Kjekshus J, Hulthe J, Muntendam P, McMurray JJ, Wikstrand J, Cleland JG, Aukrust P, Gullestad L.

Eur J Heart Fail. 2012 Mar;14(3):268-77. doi: 10.1093/eurjhf/hfs006. Epub 2012 Feb 2.

10.

Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure.

Kouris NT, Kontogianni DD, Papoulia EP, Goranitou GS, Zaharos ID, Grassos HA, Kalkandi EM, Sifaki MD, Babalis DK.

Hellenic J Cardiol. 2006 Sep-Oct;47(5):269-74.

11.

Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure.

Tamura T, Furukawa Y, Taniguchi R, Sato Y, Ono K, Horiuchi H, Nakagawa Y, Kita T, Kimura T.

Circ J. 2007 May;71(5):623-30.

12.

Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure.

Cicoira M, Rossi A, Bonapace S, Zanolla L, Golia G, Franceschini L, Caruso B, Marino PN, Zardini P.

J Card Fail. 2004 Oct;10(5):403-11.

PMID:
15470651
13.

Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.

Ishii J, Nomura M, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Ando T, Kurokawa H, Kondo T, Nagamura Y, Ezaki K, Hishida H.

Am J Cardiol. 2002 Mar 15;89(6):691-5.

PMID:
11897211
14.

High sensitivity C-reactive protein predicts nonresponders and cardiac deaths in severe heart failure patients after CRT implantation.

Kamioka M, Suzuki H, Yamada S, Kamiyama Y, Saitoh S, Takeishi Y.

Int Heart J. 2012;53(5):306-12.

15.

Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.

Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M.

Int J Cardiol. 2005 Sep 15;104(1):39-45.

PMID:
16137508
16.

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S.

Circulation. 1996 Aug 15;94(4):690-7.

17.

Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.

Tziakas DN, Chalikias GK, Stakos D, Chatzikyriakou SV, Papazoglou D, Mitrousi K, Lantzouraki A, Thomaidi A, Boudoulas H, Konstantinides S.

Eur J Prev Cardiol. 2012 Feb;19(1):62-71. doi: 10.1097/HJR.0b013e32833ace76. Epub 2011 Jan 28.

PMID:
20479644
18.

A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.

Stanton E, Hansen M, Wijeysundera HC, Kupchak P, Hall C, Rouleau JL; PRAISE-2 study investigators.

Eur J Heart Fail. 2005 Jun;7(4):557-65.

19.

B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.

van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JG, Paulus WJ, Voors AA, Hillege HL.

J Am Coll Cardiol. 2013 Apr 9;61(14):1498-506. doi: 10.1016/j.jacc.2012.12.044.

20.

Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure.

Sakai H, Tsutamoto T, Tsutsui T, Tanaka T, Ishikawa C, Horie M.

Circ J. 2006 Aug;70(8):1006-11.

Supplemental Content

Support Center